Clinical trial
Trastuzumab Plus Chemotherapy in Treating Patients With Advanced Non-small Cell…
NCT00003881 · Eastern Cooperative Oncology Group, Other · Completed
Key facts
| NCT number | NCT00003881 |
|---|---|
| Title | Trastuzumab Plus Chemotherapy in Treating Patients With Advanced Non-small Cell Lung Cancer |
| Official title | Phase II Pilot Trial of Carboplatin, Paclitaxel, and Herceptin in HER2/Neu (+) Advanced NSCLC |
| Lead sponsor | Eastern Cooperative Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Lung Cancer |
| Intervention type | Biological, Drug |
| Interventions | trastuzumab, carboplatin, paclitaxel |
| Start date | May 1, 1999 |
| Completion | Jul 1, 2004 |
| First posted | Jul 19, 2004 |
| Last update posted | Jun 21, 2013 |
| Countries | Puerto Rico, South Africa, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: